These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8866800)

  • 21. In the vertical transmission of HIV, timing may be everything.
    Pizzo PA; Butler KM
    N Engl J Med; 1991 Aug; 325(9):652-4. PubMed ID: 1861699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas.
    Carrow EW; Vujcic LK; Glass WL; Seamon KB; Rastogi SC; Hendry RM; Boulos R; Nzila N; Quinnan GV
    AIDS Res Hum Retroviruses; 1991 Oct; 7(10):831-8. PubMed ID: 1720630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for efficient vertical transfer of maternal HIV-1 envelope-specific neutralizing antibodies but no association of such antibodies with reduced infant infection.
    Omenda MM; Milligan C; Odem-Davis K; Nduati R; Richardson BA; Lynch J; John-Stewart G; Overbaugh J
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):163-6. PubMed ID: 23774880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternofetal transmission of human immunodeficiency virus-1: the role of antibodies to the V3 primary neutralizing domain.
    Rubinstein A; Goldstein H; Calvelli T; Devash Y; Rubinstein R; Soeiro R; Lyman W
    Pediatr Res; 1993 Jan; 33(1 Suppl):S76-8; discussion S78-9. PubMed ID: 8433879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human immunodeficiency virus (HIV)-positive sera obtained shortly after seroconversion neutralize autologous HIV type 1 isolates on primary macrophages but not on lymphocytes.
    Ruppach H; Nara P; Raudonat I; Elanjikal Z; Rübsamen-Waigmann H; Dietrich U
    J Virol; 2000 Jun; 74(12):5403-11. PubMed ID: 10823844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral phenotype in mother-to-child HIV-1 transmission and disease progression of vertically acquired HIV-1 infection.
    De Rossi A; Ometto L; Masiero S; Zanchetta M; Chieco-Bianchi L
    Acta Paediatr Suppl; 1997 Jun; 421():22-8. PubMed ID: 9240853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viral studies of mothers with human immunodeficiency virus infection at delivery and their infants in the first 3 days of life.
    Sison AV; Brandt CD; Rakusan TA; Wientzen R; Fuccillo DA; Sever JL
    Pediatr AIDS HIV Infect; 1996 Oct; 7(5):325-30. PubMed ID: 11361490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of maternal cytophilic human immunodeficiency virus (HIV)-1 V3 loop peptide-specific antibodies in infants with vertical HIV transmission.
    Wang XP; Oyaizu N; Pahwa S
    Pediatr Res; 1995 Sep; 38(3):384-9. PubMed ID: 7494664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection.
    Supapol WB; Remis RS; Raboud J; Millson M; Tappero J; Kaul R; Kulkarni P; McConnell MS; Mock PA; Culnane M; McNicholl J; Roongpisuthipong A; Chotpitayasunondh T; Shaffer N; Butera S
    J Infect Dis; 2008 May; 197(10):1369-77. PubMed ID: 18419578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission.
    Permar SR; Fong Y; Vandergrift N; Fouda GG; Gilbert P; Parks R; Jaeger FH; Pollara J; Martelli A; Liebl BE; Lloyd K; Yates NL; Overman RG; Shen X; Whitaker K; Chen H; Pritchett J; Solomon E; Friberg E; Marshall DJ; Whitesides JF; Gurley TC; Von Holle T; Martinez DR; Cai F; Kumar A; Xia SM; Lu X; Louzao R; Wilkes S; Datta S; Sarzotti-Kelsoe M; Liao HX; Ferrari G; Alam SM; Montefiori DC; Denny TN; Moody MA; Tomaras GD; Gao F; Haynes BF
    J Clin Invest; 2015 Jul; 125(7):2702-6. PubMed ID: 26053661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A survey of children with HIV/AIDS in highly epidemic villages of AIDS].
    Zhuang K; Gui XE; Luo JL; Wang XR; Su B; Zhang YX
    Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):586-9. PubMed ID: 14744378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Broad cross-neutralizing activity in serum is associated with slow progression and low risk of transmission in primate lentivirus infections.
    Fenyö EM; Putkonen P
    Immunol Lett; 1996 Jun; 51(1-2):95-9. PubMed ID: 8811351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between maternal-infant antibody levels and vertical transmission of HIV-1 infection.
    Moodley D; Coovadia HM; Bobat RA; Madurai S; Sullivan JL
    J Trop Pediatr; 1997 Apr; 43(2):75-9. PubMed ID: 9143175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The vertical transmission of human immunodeficiency virus type 1: molecular and biological properties of the virus.
    Ahmad N
    Crit Rev Clin Lab Sci; 2005; 42(1):1-34. PubMed ID: 15697169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of virologic and immunologic factors in mother-to-child transmission of HIV-1.
    Colognesi C; Halapi E; Jansson M; Hodara V; Steuer G; Tresoldi E; Leitner T; Scarlatti G
    Am J Reprod Immunol; 1997 Sep; 38(3):197-200. PubMed ID: 9325492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low conservation of functional domains of HIV type 1 vif and vpr genes in infected mothers correlates with lack of vertical transmission.
    Yedavalli VR; Ahmad N
    AIDS Res Hum Retroviruses; 2001 Jul; 17(10):911-23. PubMed ID: 11461677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load.
    Dickover RE; Garratty EM; Herman SA; Sim MS; Plaeger S; Boyer PJ; Keller M; Deveikis A; Stiehm ER; Bryson YJ
    JAMA; 1996 Feb; 275(8):599-605. PubMed ID: 8594240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission Risk.
    Martinez DR; Vandergrift N; Douglas AO; McGuire E; Bainbridge J; Nicely NI; Montefiori DC; Tomaras GD; Fouda GG; Permar SR
    J Virol; 2017 May; 91(9):. PubMed ID: 28202762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation between HIV-1 syncytium inhibition antibodies and clinical outcome in children.
    Brenner TJ; Dahl KE; Olson B; Miller G; Andiman WA
    Lancet; 1991 Apr; 337(8748):1001-5. PubMed ID: 1673167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vertical transmission of HIV in Ghanaian women diagnosed in cord blood and post-natal samples.
    Fischetti L; Danso K; Dompreh A; Addo V; Haaheim L; Allain JP
    J Med Virol; 2005 Nov; 77(3):351-9. PubMed ID: 16173021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.